Nurse-led and Interdisciplinary Secondary Cardiovascular Prevention Programmes: Spanish Cohort of the EUROACTION Project

Author:

Buigues Cristina12ORCID,Trapero Isabel1ORCID,Velasco Jose Antonio3,Salvador-Sanz Antonio4,Jennings Catriona5ORCID,Wood David56,Queralt Ana17ORCID

Affiliation:

1. Department of Nursing, University of Valencia, Valencia, Spain

2. Frailty and Cognitive Impairment Group (FROG), University of Valencia, Valencia, Spain

3. Cardiology Service, Hospital General Universitario, Valencia, Spain

4. Cardiology Department, Valencian Institute of Oncology Foundation, Valencia, Spain

5. National Institute for Prevention and Cardiovascular Health, National University of Ireland – Galway, Ireland

6. Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London (Hammersmith Campus), International Centre for Circulatory Health, London, UK

7. AFIPS Research Group, University of Valencia, Valencia, Spain

Abstract

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are a preventive tool, which can reverse unhealthy behaviours and improve risk factor management. They have been successfully implemented in a variety of settings in patients with coronary heart disease (CHD). Objective: The objective of this study is to evaluate an interdisciplinary and nurse-led cardiovascular prevention and rehabilitation programme in patients with coronary heart disease. Method: Six pairs of hospitals were randomised between intervention (INT) and usual care (UC) patients. The interdisciplinary team in the intervention hospital carried out a 16-week CVPRP to reach European risk factor goals. The trial is registered as ISRCTN 71715857. Results: The proportion of patients achieving European cardiovascular recommendations in Spain increased in the intervention hospital, mainly regarding fruit and vegetable consumption (INT 98% vs. UC 53%, p<0.001), oily fish consumption (INT 42% vs. UC 19.5%, p<0.001), self-reported physical activity (INT 31% vs. UC 12.4%, p=0.04), blood pressure (INT 69% vs. UC 47.1%) p< 0.05) and LDL concentrations (INT 86.1% vs. UC 67.6%, p=0.04). Conclusion: The EUROACTION nurse-led model of CVPR programme has shown that therapeutic goals in cardiovascular disease prevention are affordable and sustainable in everyday clinical practice. EUROACTION model adapted in Spain has produced a healthier lifestyle. Clinical Trial: Trial registration No. ISRCTN 71715857.

Publisher

Bentham Science Publishers Ltd.

Subject

Immunology and Allergy,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Kotseva K.; De Backer G.; De Bacquer D.; Rydén L.; Hoes A.; Grobbee D.; Maggioni A.; Marques-Vidal P.; Jennings C.; Abreu A.; Aguiar C.; Badariene J.; Bruthans J.; Castro Conde A.; Cifkova R.; Crowley J.; Davletov K.; Deckers J.; De Smedt D.; De Sutter J.; Dilic M.; Dolzhenko M.; Dzerve V.; Erglis A.; Fras Z.; Gaita D.; Gotcheva N.; Heuschmann P.; Hasan-Ali H.; Jankowski P.; Lalic N.; Lehto S.; Lovic D.; Mancas S.; Mellbin L.; Milicic D.; Mirrakhimov E.; Oganov R.; Pogosova N.; Reiner Z.; Stöerk S.; Tokgözoğlu, L.; Tsioufis, C.; Vulic, D.; Wood, D. EUROASPIRE Investigators*. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol 2019,26(8),824-835

2. Kotseva K.; Wood D.; De Backer G.; De Bacquer D.; Pyörälä K.; Keil U.; Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet EUROASPIRE Study Group2009,373(9667),929-940

3. Piepoli M.F.; Hoes A.W.; Agewall S.; Albus C.; Brotons C.; Catapano A.L.; Cooney M-T.; Corrà U.; Cosyns B.; Deaton C.; Graham I.; Hall M.S.; Hobbs F.D.R.; Løchen M.L.; Löllgen H.; Marques-Vidal P.; Perk J.; Prescott E.; Redon J.; Richter D.J.; Sattar N.; Smulders Y.; Tiberi M.; van der Worp H.B.; van Dis I.; Verschuren W.M.M.; Binno S.; 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The sixth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the european association for cardiovascular prevention

4. Kotseva K.; Wood D.; De Bacquer D.; De Backer G.; Rydén L.; Jennings C.; Gyberg V.; Amouyel P.; Bruthans J.; Castro Conde A.; Cífková R.; Deckers J.W.; De Sutter J.; Dilic M.; Dolzhenko M.; Erglis A.; Fras Z.; Gaita D.; Gotcheva N.; Goudevenos J.; Heuschmann P.; Laucevicius A.; Lehto S.; Lovic D.; Miličić D.; Moore, D.; Nicolaides, E.; Oganov, R.; Pajak, A.; Pogosova, N.; Reiner, Z.; Stagmo, M.; Störk, S.; Tokgözoğlu, L.; Vulic, D. EUROASPIRE Investigators. EUROASPIRE IV: A european society of cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 2016,23(6),636-648

5. Grau M.; Elosua R.; Cabrera de León A.; Guembe M.J.; Baena-Díez J.M.; Vega Alonso T.; Javier Félix F.; Zorrilla B.; Rigo F.; Lapetra J.; Gavrila D.; Segura A.; Sanz H.; Fernández-Bergés D.; Fitó M.; Marrugat J.; [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: The DARIOS study] Rev Esp Cardiol 2011,64(4),295-304

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3